Nasdaq · Healthcare

Alpha Teknova, Inc. (TKNO)

As-reported financials and recent SEC filings for Alpha Teknova, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$40.5M

Net income

$-17.3M

Net margin

-42.6%

Diluted EPS

$-0.32

ROE

-25.1%

P/E (TTM)

—

Market cap

—

Debt / equity

0.2×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$40.5M	$37.7M	$36.7M	$41.4M	$36.9M
Gross profit	$13.4M	$7.2M	$10.3M	$17.5M	$17.6M
Operating income	$-17.0M	$-26.1M	$-35.6M	$-49.7M	$-12.0M
Net income	$-17.3M	$-26.7M	$-36.8M	$-47.5M	$-9.8M
Diluted EPS	$-0.32	$-0.57	$-1.16	$-1.69	$-0.61

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

42026-06-02

42026-06-02

42026-06-02

8-K2026-06-01

10-Q2026-05-07

8-K2026-05-06

ARS2026-04-21

DEFA14A2026-04-21

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on TKNO

Search Alpha Teknova, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.